yaniv406
Posted - 3 days ago
$APTO At least it's over soon and they're closing the company
yaniv406
Posted - 3 days ago
$APTO I warned here that they were thieves and no one wanted to listen
yaniv406
Posted - 3 days ago
$APTO Bankruptcy on the way...
yaniv406
Posted - 3 days ago
$APTO By the end of the year another reverse split, next year bankruptcy.
yaniv406
Posted - 4 days ago
$APTO How not to kick her out of business
TechnicalAbe47
Posted - 1 week ago
@Racerron $nvax? $apto?
yaniv406
Posted - 1 week ago
$APTO 💥💥✈️🚀
yaniv406
Posted - 1 week ago
$APTO ✈️✈️✈️Just keep going up, galactic blast
FoolishSpeculator
Posted - 1 week ago
$APTO Absolute long-term shareholder value destruction ... nice. I like this bag because it reminds me not to gamble.
yaniv406
Posted - 2 weeks ago
$APTO They have run out of people who will try to market the company here, I will tell you what this company is doing stealing money and selling lies wrapped in gold .
This company was worth 700 million dollars 3 years ago all the money evaporated now it is worth barely 20 million and in my opinion it is worth 💩💩💩💯
yaniv406
Posted - 2 weeks ago
$APTO A friend asks when we reach zero
yaniv406
Posted - 2 weeks ago
$APTO reach the moon 🤣🤣
yaniv406
Posted - 2 weeks ago
$APTO 💩💩💩💩💩
HtownTrad3r
Posted - 03/28/24
$APTO shorting
ChiefOG
Posted - 03/28/24
$APTO 🔥
yaniv406
Posted - 03/27/24
$APTO Sell this crap and buy Nvidia, why throw the money down the toilet .
yaniv406
Posted - 03/27/24
$APTO 💩💩💩💩
epsguid
Posted - 03/26/24
$APTO reported a loss of $1.44, consensus was ($1.48) via @eWhispers #epsbeat http://eps.sh/d/apto
DonCorleone77
Posted - 03/26/24
$APTO Aptose Biosciences proceeds from closing of public offering Jan 30 $9.7M On January 30, Aptose closed a public offering of 5,649,122 common shares of the Company and warrants at a combined offering price of $1.71 per share. This included 736,842 Common Shares and warrants pursuant to a full exercise by the underwriter of its over-allotment option. Total gross proceeds from the public offering were approximately $9.7M before deducting underwriting costs, placement agent commissions and other offering-related expenses.
DonCorleone77
Posted - 03/26/24
$APTO 2 of 2 - Aptose Biosciences reports FY23 EPS ($7.58) vs ($6.80) last year ....demonstrated a distinctly favorable safety profile and broad activity for tuspetinib across mutational subtypes. This profile also extends to FLT3 wildtype AML, which represents the majority of AML patients, and in which few agents have shown such broad activity," said William G. Rice, Ph.D., Chairman, President and Chief Executive Officer. "These data have propelled us to initiate a clinical study of tuspetinib in a triplet combination with venetoclax and azacitidine in frontline therapy for newly diagnosed AML, including both FLT3 wild type and FLT3 mutated subtypes."
DonCorleone77
Posted - 03/26/24
$APTO 1 of 2 - Aptose Biosciences reports FY23 EPS ($7.58) vs ($6.80) last year Cash and cash equivalents, January 31 was $18.6M , after gross proceeds from January 2024 financings of $13.7M... Total cash and cash equivalents and investments as of December 31, 2023, were $9.3M a decrease of $37.7 M as compared to $47.M at December 31, 2022. Based on current operations, the Company expects that cash on hand and available capital provide the Company with sufficient resources to fund planned company operations including research and development through August of 2024.R&D expenses increased by $8.7 Mto $36.8M for the year ended December 31 as compared with $28.1M for the comparative period in 2022. Changes to the components of our R&D expenses presented in the table above are primarily related to the following activities: "The data we have generated from tuspetinib thus far - as a single agent and in combination therapy with venetoclax in relapsed and refractory AML - have...
Stock_Titan
Posted - 03/26/24
$APTO Aptose Reports Results for the Fourth Quarter and Full Year 2023
https://www.stocktitan.net/news/APTO/aptose-reports-results-for-the-fourth-quarter-and-full-year-5c2mkm8nou0u.html
FINTECFA
Posted - 03/26/24
$APTO anything here?
GPS_OS_21_vs_SOC_5
Posted - 03/23/24
@MK_bio @INTS915 ints, you prolly aren’t familiar with 009, but the AML P2 Triplet ( 009 Aza Ven ) will have you selling your $apto / i saw the ceo speak at the CF conference- less than meh. - lets circle back Tuesday and lmk what you think?
TickerDD_com
Posted - 03/21/24
From 3/8/2024, looking back across 22 Month-Ends for APTO, Percentage Change of Average Monthly Price had More Negatives (64%) while Percentage Change of Average Monthly Volume had All Positives (100%) $APTO #APTO #APTOStock #TickerDD https://www.youtube.com/watch?v=jBau8pIFi6o
INTS915
Posted - 03/20/24
$APTO , This 10 fold soon...wait my friends.
yaniv406
Posted - 03/20/24
$APTO One day this stock will be Nvidia only in the opposite direction and in a stronger form 🙈
INTS915
Posted - 1 month ago
$APTO , 1.59 need to break. Next stop 2.22.
INTS915
Posted - 1 month ago
$APTO , Data releasing on 26th March...get in before this goes parabolic.
Stock_Titan
Posted - 1 month ago
$APTO Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024
https://www.stocktitan.net/news/APTO/aptose-to-report-fourth-quarter-and-year-end-2023-financial-results-ifrkydj1prye.html